News|Articles|January 2, 2024
Reducing Risk in Bioproduction with Facilities Equivalency (Jan 2024)
Author(s)Thermo Fisher Scientific
Media manufacturers must offer global redundancy at harmonized manufacturing facilities to enable streamlined capabilities–especially for their customers outsourcing proprietary cell culture media formulations. This paper details Thermo Fisher’s manufacturing equivalency approach utilized at two global facilities located in Miami, Florida, and Grand Island, New York.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
2
Innovation and Market Exclusivity in the EU
3
FDA Approval of Cytokinetics’ Myqorzo Reflects Specialty Cardio Drug Trend
4
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
5